Literature DB >> 20506129

Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography.

Michael W Wolff1, Corina Siewert, Sara Post Hansen, Rene Faber, Udo Reichl.   

Abstract

A purification scheme for cell culture-derived smallpox vaccines based on an orthogonal downstream process of pseudo-affinity membrane adsorbers (MA) and hydrophobic interaction chromatography (HIC) was investigated. The applied pseudo-affinity chromatography, based on reinforced sulfated cellulose and heparin-MA, was optimized in terms of dynamic binding capacities, virus yield and process productivity. HIC was introduced as a subsequent method to further reduce the DNA content. Therefore, two screens were undertaken. First, several HIC ligands were screened for different adsorption behavior between virus particles and DNA. Second, elution from pseudo-affinity MA and adsorption of virus particles onto the hydrophobic interaction matrix was explored by a series of buffers using different ammonium sulfate concentrations. Eventually, variations between different cultivation batches and buffer conditions were investigated.The most promising combination, a sulfated cellulose membrane adsorber with subsequent phenyl HIC resulted in overall virus particle recoveries ranging from 76% to 55% depending on the product batch and applied conditions. On average, 61% of the recovered virus particles were infective within all tested purification schemes and conditions. Final DNA content varied from 0.01% to 2.5% of the starting material and the level of contaminating protein was below 0.1%.

Entities:  

Mesh:

Year:  2010        PMID: 20506129     DOI: 10.1002/bit.22797

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  9 in total

Review 1.  Plant-derived virus-like particles as vaccines.

Authors:  Qiang Chen; Huafang Lai
Journal:  Hum Vaccin Immunother       Date:  2012-09-20       Impact factor: 3.452

2.  Interference chromatography: a novel approach to optimizing chromatographic selectivity and separation performance for virus purification.

Authors:  Lisa A Santry; Renaud Jacquemart; Melissa Vandersluis; Mochao Zhao; Jake M Domm; Thomas M McAusland; Xiaojiao Shang; Pierre M Major; James G Stout; Sarah K Wootton
Journal:  BMC Biotechnol       Date:  2020-06-17       Impact factor: 2.563

Review 3.  Downstream processing of cell culture-derived virus particles.

Authors:  Michael W Wolf; Udo Reichl
Journal:  Expert Rev Vaccines       Date:  2011-10       Impact factor: 5.217

Review 4.  Large-scale production and purification of VLP-based vaccines.

Authors:  Tiago Vicente; António Roldão; Cristina Peixoto; Manuel J T Carrondo; Paula M Alves
Journal:  J Invertebr Pathol       Date:  2011-07       Impact factor: 2.841

Review 5.  Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Authors:  Ingo Jordan; Verena Lohr; Yvonne Genzel; Udo Reichl; Volker Sandig
Journal:  Microorganisms       Date:  2013-11-01

6.  Purification of influenza virus-like particles using sulfated cellulose membrane adsorbers.

Authors:  Sofia B Carvalho; A Raquel Fortuna; Michael W Wolff; Cristina Peixoto; Paula M Alves; Udo Reichl; Manuel Jt Carrondo
Journal:  J Chem Technol Biotechnol       Date:  2017-12-16       Impact factor: 3.174

Review 7.  Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance.

Authors:  Guy-Alain Junter; Laurent Lebrun
Journal:  J Pharm Anal       Date:  2020-01-13

8.  Development of a downstream process for the production of an inactivated whole hepatitis C virus vaccine.

Authors:  Keven Lothert; Anna F Offersgaard; Anne F Pihl; Christian K Mathiesen; Tanja B Jensen; Garazi Peña Alzua; Ulrik Fahnøe; Jens Bukh; Judith M Gottwein; Michael W Wolff
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

Review 9.  Recombinant modified vaccinia virus Ankara-based malaria vaccines.

Authors:  Sarah Sebastian; Sarah C Gilbert
Journal:  Expert Rev Vaccines       Date:  2015-10-29       Impact factor: 5.683

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.